Search

Your search keyword '"Park JN"' showing total 179 results

Search Constraints

Start Over You searched for: Author "Park JN" Remove constraint Author: "Park JN"
179 results on '"Park JN"'

Search Results

1. Engaging people who inject drugs in hepatitis C virus testing and prevention through community-based outreach, in Sydney, Australia

2. Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: Perspectives of people who inject drugs.

Catalog

Books, media, physical & digital resources

3. Prevalence and correlates of fentanyl test strip use among people who use drugs in Rhode Island.

4. "Politics Versus Policy": Qualitative Insights on Stigma and Overdose Prevention Center Policymaking in the United States.

5. Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon.

6. Epidemiology of drug arrests in the United States: Evidence from the national survey on drug use and health, 2015-2019.

7. U.S. policy responses to xylazine: Thinking bigger.

8. An urgent need for community lot testing of lateral flow fentanyl test strips marketed for harm reduction in Northern America.

9. Xylazine awareness, desire, use and exposure: Preliminary findings from the Rhode Island community-based drug checking cohort study.

10. Knowledge, Attitudes, and Beliefs About Opioid Use Disorder Treatment in Primary Care.

11. High-dose naloxone formulations are not as essential as we thought.

12. Pilot findings on the real-world performance of xylazine test strips for drug residue testing and the importance of secondary testing methods.

13. Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid Settlement.

14. Acceptability of Event-Driven and Long-Acting HIV Pre-Exposure Prophylaxis Formulations Among Transgender Women Engaged in Street-Based Sex Work in Baltimore, Maryland.

15. Association between willingness to use an overdose prevention center and probation or parole status among people who use drugs in Rhode Island.

16. "Make yourself un-NIMBY-able": stakeholder perspectives on strategies to mobilize public and political support for overdose prevention centers in the United States of America.

17. Factors associated with daily use of benzodiazepines/tranquilizers and opioids among people who use drugs.

18. Supervised Inhalation Sites: Preventing Overdose and Reducing Health Inequities among People Who Use Drugs.

19. Costing analysis of a point-of-care drug checking program in Rhode Island.

20. Implementation of Overdose Prevention in Maryland: Implications for Resource Allocation, Program Scale-Up, and Evaluation.

21. Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the United States.

22. A survey of North American drug checking services operating in 2022.

23. Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes.

24. Xylazine in the drug supply: A research agenda.

25. Evaluating the Impact of Brave Technology Co-op's Novel Drug Overdose Detection and Response Devices in North America: a Retrospective Study.

26. Retention and Overdose Risk among Patients Receiving Substance Use Disorder Treatment, Mental Health Care and Peer Recovery Support: A Longitudinal Analysis.

27. High-Dose Naloxone Formulations Are Not as Essential as We Thought.

28. Communicative appeals and messaging frames in visual media for HIV pre-exposure prophylaxis promotion to cisgender and transgender women.

31. A Capacity-Strengthening Intervention to Support HIV Pre-exposure Prophylaxis (PrEP) Awareness-Building and Promotion by Frontline Harm Reduction Workers in Baltimore, Maryland: A Mixed Methods Evaluation.

32. Disruptions to naloxone training among lay and occupational responders in Maryland during the emergence of COVID-19: early impacts, recovery, and lessons learned.

33. Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study.

34. Safety in solitude? Competing risks and drivers of solitary drug use among women who inject drugs and implications for overdose detection.

35. A Novel Capacity-Strengthening Intervention for Frontline Harm Reduction Workers to Support Pre-exposure Prophylaxis Awareness-Building and Promotion Among People Who Use Drugs: Formative Research and Intervention Development.

36. Overdose Detection Technologies to Reduce Solitary Overdose Deaths: A Literature Review.

37. Validation of a lateral flow chromatographic immunoassay for the detection of fentanyl in drug samples.

38. Discordance Between Self-reported and Biologically Tested Exposure to Fentanyl Among People at Risk of Opioid Overdose.

39. Unsolicited reporting notifications (URNs) through Maryland's prescription drug monitoring program (PDMP): Characteristics of providers.

40. High Cholesterol-Induced Bone Loss Is Attenuated by Arctiin via an Action in Osteoclasts.

41. Acceptability of Overdose Prevention Sites in the Business Community in Baltimore, Maryland.

42. Provider Perspectives on HIV Pre-Exposure Prophylaxis Service Disruptions and Adaptations During the COVID-19 Pandemic in Baltimore, Maryland: A Qualitative Study.

43. Doxorubicin Induces Bone Loss by Increasing Autophagy through a Mitochondrial ROS/TRPML1/TFEB Axis in Osteoclasts.

44. Mapping Interests in Event-Driven and Long-Acting Pre-exposure Prophylaxis Formulations onto the HIV Risk Environment of Street-Based Female Sex Workers: A Latent Class Analysis.

45. Morin Disrupts Cytoskeleton Reorganization in Osteoclasts through an ROS/SHP1/c-Src Axis and Grants Protection from LPS-Induced Bone Loss.

46. Area-level deprivation and adverse childhood experiences among high school students in Maryland.

47. Latent Classes of Polysubstance Use and Associations with HIV Risk and Structural Vulnerabilities among Cisgender Women Who Engage in Street-Based Transactional Sex in Baltimore City.

48. Detecting early-stage malignant melanoma using a calcium switch-enriched exosome subpopulation containing tumor markers as a sample.

49. HIV Risk Among Urban and Suburban People Who Inject Drugs: Elevated Risk Among Fentanyl and Cocaine Injectors in Maryland.

50. Alternative use of buprenorphine among people who use opioids in three U.S. Cities.